Shorla Pharma emphasizes how specialty pharmacy is streamlining commercialization in an unpredictable market and maximizing brand value in the oncology space through valuable partnership.
Watch the full interview with Bio Europe and Sharon Cunningham, CEO, Shorla Pharma. Shorla Pharma, a specialty pharmaceutical company, shares their partnership journey with EVERSANA to bypass the traditional commercialization model that’s too inefficient, costly and cumbersome. Mike and Sharon share their vision of an integrated model that’s streamlined to maximize brand value and improve patient access and outcomes.
Bio-Europe “Collaboration Close-Up”: Exploring the EVERSANA – Shorla Pharma Partnership